Patient / Public:
Health Professional:
Article Opinions:	0 posts

Post Of Zambia Examines Toll Of HIV/AIDS On Country

The Post of Zambia examines the findings of a recent report revealing “the devastating effects” the HIV/AIDS epidemic in Zambia is having on the country’s ability to meet the U.N. Millennium Development Goals. The article also looks at the relationship between HIV/AIDS and nutrition, maternal health and education (Chackwe, 9/21).

Ugandan Government Works To Attract Medical Workers

The Ugandan government will soon begin centralizing the recruitment of medical workers in an effort to improve health services and reduce health worker shortages, Health Minister Stephen Mallinga announced Wednesday, the New Vision/allAfrica.com reports (Edyegu, 9/18).

Science Insider Blog Features Interview With U.S. Global AIDS Coordinator

Science magazine’s “Science Insider” blog interviewed Eric Goosby before his official swearing-in ceremony last week as the Global AIDS Coordinator and Ambassador-at-Large for the U.S. government. The interview covers several topics, including his plans for PEPFAR, targeting the demographic of the HIV epidemic and funding ideas (9/18).

Carson Speech Published By AllAfrica.com

allAfrica.com published a transcript of Assistant Secretary of State for Africa Johnnie Carson’s recent speech at the Center for American Progress in Washington, D.C. The Obama administration “will also continue to maintain our historical focus on health issues with a particular emphasis on public health and the strengthening of African delivery systems to provide the kinds of access, treatment and prevention that remain essential for progress in most other areas,” Carson said (9/17).

AP/Washington Post Examines South African Health Care Reform Efforts

South Africa’s “governing African National Congress party wants to pass universal health insurance before President Jacob Zuma’s first term ends in five years,” and most people in the country “believe the plan will pass,” the Associated Press/Washington Post reports. The article includes quotes from a public forum addressing the country’s health care system and notes that questions remain about how reform “could be funded and whether it would fix the troubled health system in South Africa, which has an estimated 5.5 million people living with HIV - the highest total of any country” (Bryson, 9/17).

African Countries Use Text Messages To Report Local Drug Shortages

PlusNews/IRIN examines how a program launched earlier this year in Kenya, Uganda, Malawi and Zambia is helping people to use text messages to report shortages of “essential medicines to treat common diseases such as malaria, pneumonia, diarrhoea, HIV and tuberculosis” at their local clinics or hospital pharmacies. “Stock-outs often mean that poor patients, who cannot afford to travel to other health facilities or to buy drugs from the private sector, simply go without, risking serious health consequences,” the news service writes (9/17).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

Patient / Public:
Health Professional:
Article Opinions:	0 posts

UNAIDS Executive Director Michel Sidibe in New York on Monday signed a partnership agreement with several non-governmental organizations (NGOs) pledging to work towards eliminating mother-to-child transmission of HIV in Africa, Agence France-Presse reports. Presidents Abdoulaye Wade of Senegal and Yoweri Museveni of Uganda attended the signing ceremony.

“Signatories include Columbia University’s Earth Institute led by leading U.S. economist Jeffrey Sachs and the Millennium Promise Alliance, an advocacy group pushing for implementation of the” Millennium Development Goals in Africa, the news service writes. The agreement, “signed as world leaders gathered here for this week’s U.N. General Assembly session, aims to accelerate action on HIV/AIDS and ‘correct the glaring inequality’ faced by children in the face of the scourge … Sidibe told a press conference.” According to Sidibe, each year more than 300,000 babies are born HIV positive, “most of them in Africa and 30 percent of them died before their first birthday, he added.”

The agreement aims to prevent women from acquiring HIV, prevent unintended pregnancies, prevent the mother-to-child transmission of the virus and offer services to women and children affected by the disease (9/21). A UNAIDS press release provides additional information on the specifics of programs working to achieve the goals of the agreement (9/21).

This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org.

© Henry J. Kaiser Family Foundation. All rights reserved.

Four scientists have been selected as this year’s winners of the Avant-Garde Award for HIV/AIDS research, the National Institute on Drug Abuse, part of the National Institutes of Health, announced today. The annual award competition, now in its second year, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in drug abusers. Winning scientists receive $500,000 per year, plus associated facilities and administrative costs, for five years to support their research.

The four awardees will undertake diverse approaches in their research on HIV. One scientist will investigate the interactions that occur between HIV-infected and uninfected cells during intravenous transmission. Another researcher is developing new strategies to restore the immune system of HIV-infected individuals. The third will work on developing a new technology that exploits a silencing mechanism to block HIV transcription. The last will focus on identifying and eliminating latent HIV infection. This collective research will further NIDA’s work to learn more about the pivotal role of drug abuse in the spread of HIV/AIDS and to develop effective strategies to prevent and treat this disease.

The Avant-Garde Awards are modeled after the NIH Pioneer Awards and are granted to scientists of exceptional creativity who propose high-impact research that will open new avenues for prevention and treatment of HIV/AIDS among drug abusers. “By supporting bold investigators with unexplored ideas, we hope we can find new approaches to eradicating the terrible public health toll of HIV/AIDS,” said NIH Director Francis Collins.

“This year’s Avant-Garde recipients proposed some especially exciting research directions,” said NIDA Director Nora D. Volkow, who announced the awards. “These studies of fundamental processes in HIV infection should move us ahead by leaps and bounds in our efforts to find solutions to HIV/AIDS.”

The Avant-Garde Awardees were selected from 39 applicants whose proposals reflect diverse scientific disciplines and approaches to HIV/AIDS research. The Avant-Garde Awards were granted to the following researchers:

Awardee: Benjamin K. Chen, M.D., Ph.D., assistant professor in the Department of Infectious Diseases at Mount Sinai School of Medicine, New York, is an investigator of exceptional vision and promise. He developed methodology that enables visualization of fluorescently tagged HIV virus particles that may answer long-standing questions about cell-cell mechanisms of viral transmission.

Project: Imaging Virological Synapses During Parenteral HIV Transmission

The understanding of how the HIV virus spreads among injection drug users is limited by a poor understanding of the first events that occur following HIV transmission. This research uses sensitive virus tagging approaches and mouse models with humanized immune systems to study the sequence of interactions between HIV-infected cells and uninfected cells. These studies may lead to the development of vaccines or other preventive approaches to inhibit these initial interactions that occur during intravenous transmission.

Awardee: Dana H. Gabuzda, M.D., is a professor of neurology (microbiology) at the Dana Farber Cancer Institute and Harvard Medical School, in Boston. Dr. Gabuzda is a leading researcher in the areas of HIV molecular biology and pathogenesis, particularly neuropathogenesis. Her cutting-edge research has significantly increased understanding of HIV replication and pathogenesis.

Project: Systems Biology of Immune Reconstitution in HIV/AIDS

A major challenge in HIV research is to restore immune function in HIV-infected individuals. HIV infection depletes CD4 T cells, leading to immunodeficiency and death. Highly active anti-retroviral therapy (HAART) restores CD4 T cell counts to normal levels in a majority of individuals who achieve suppression of HIV to undetectable levels. However, the magnitude of CD4 T cell recovery is variable and many people on HAART have poor CD4 T cell recovery. The research will lead to a better understanding of the mechanisms that determine CD4 T cell restoration in IV drug abusers and other populations infected with HIV, and may identify new therapeutic strategies to improve restoration of immune function in these populations.

Awardee: Jonathan Karn, Ph.D., is a professor and chairman of molecular biology and microbiology at Case Western Reserve University, in Cleveland. Dr. Karn is a creative molecular biologist whose research on novel therapeutic technologies could have an impact on the HIV/AIDS epidemic worldwide.

Project: Manipulating Epigenetic Control Mechanisms to Control HIV Transcription

Most individuals treated with antiretroviral drugs have little to no detectable HIV in their blood, however, this does not mean that the virus has been cleared from the body. Unfortunately, the virus can re-emerge, leading to renewed active infections when treatment stops or fails. This research will focus on finding natural mechanisms that could block HIV replication and provide long-lasting suppression of HIV.

Awardee: Rafick-Pierre Sekaly, Ph.D., scientific director and co-director of the Oregon Health and Science University Vaccine and Gene Therapy Institute in Portland is an internationally recognized leader in the field of human immunology and translational medicine, specifically the immune response to HIV infection.

Project: Novel Concepts for the Eradication of HIV

The HIV-1 reservoir is a small pool of persistent long-lived and latently infected resting memory CD4 T cells. Eradication of this HIV reservoir is one of the last steps to be conquered in order to develop a cure for this disease. Dr. Sekaly’s research will probe for a mechanism explaining the existence of HIV reservoirs. His studies of pathways that can be targeted to purge HIV from its reservoir could ultimately lead to novel immunological interventions for the treatment of HIV.

NIDA’s HIV/AIDS Research Program supports a multidisciplinary portfolio that investigates the role of drug use and its related behaviors in the evolving dynamics of HIV/AIDS epidemiology, natural history/pathogenesis, treatment, and prevention. http://www.drugabuse.gov/AIDS.

For further information about the Avant-Garde Award, please visit the NIDA Avant-Garde Award Web site at http://drugabuse.gov/avgp.html. Information about the FY10 Avant-Garde award will be posted on this site soon.

Source
The National Institute on Drug Abuse